YIL014C-A Antibody

What is YIL014C-A and what cellular functions is it associated with?

YIL014C-A is a systematic gene identifier in Saccharomyces cerevisiae (budding yeast) that has been studied in the context of metal ion toxicity and stress responses. The protein encoded by this gene has been implicated in cellular pathways related to metal ion homeostasis, particularly in response to exposure to metals such as zinc, aluminum, and arsenic. Research has shown that YIL014C-A may play a role in cellular defense mechanisms against metal toxicity, potentially through interactions with protein kinase CK2 pathways .

When studying YIL014C-A, it's important to understand that yeast gene nomenclature follows specific conventions: the italicized capital letters (e.g., YIL014C-A) refer to the gene, while the protein product is typically denoted with a capital first letter followed by lowercase letters and a "p" suffix. Deletion mutants are represented by lowercase italics followed by the Greek letter delta (e.g., yil014c-aΔ) .

How does YIL014C-A relate to protein kinase CK2 signaling pathways?

YIL014C-A has been studied in relation to protein kinase CK2 signaling, particularly in the context of metal ion toxicity. Protein kinase CK2 (formerly known as Casein kinase 2) is a highly conserved serine/threonine kinase that plays crucial roles in various cellular processes. In yeast, CK2 consists of catalytic subunits (Cka1p and Cka2p) and regulatory subunits, which are orthologous to mammalian CK2α, CK2α', and CK2β .

Research has shown that protein kinase CK2 is involved in metal ion toxicity responses, with different subunits potentially having distinct functions. For instance, the CKA1 subunit appears to have a prominent role in zinc sequestration . YIL014C-A may interact with these pathways, potentially affecting cellular responses to metal exposure. Understanding these interactions is critical for researchers developing antibodies against YIL014C-A, as it provides context for experimental design and interpretation of results.

What are the optimal conditions for using YIL014C-A antibodies in Western blot analyses?

When using YIL014C-A antibodies for Western blot analyses, researchers should consider several methodological factors to ensure optimal results:

• Sample preparation: Yeast cell lysates should be prepared using methods that preserve protein integrity. A recommended approach involves mechanical disruption with glass beads in buffer containing protease inhibitors.

• Protein denaturation: Use sample buffer containing SDS and reducing agents like β-mercaptoethanol, with heating at 95°C for 5 minutes.

• Gel percentage: 10-12% SDS-PAGE gels are typically appropriate for resolving yeast proteins in the expected molecular weight range.

• Transfer conditions: Semi-dry transfer at 15V for 30-45 minutes using PVDF membranes provides good results for most yeast proteins.

• Blocking: 5% non-fat dry milk in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature is recommended to minimize background.

• Primary antibody dilution: Start with a 1:1000 dilution of YIL014C-A antibody and optimize as needed. Incubate overnight at 4°C for best results.

• Washing: Perform 3-5 washes with TBST, 5 minutes each.

• Secondary antibody: Use appropriate species-specific HRP-conjugated secondary antibody at 1:5000 dilution.

The specificity of YIL014C-A antibodies should be validated using appropriate controls, including yeast strains with YIL014C-A deletions to confirm antibody specificity .

How can YIL014C-A antibodies be optimized for immunoprecipitation experiments in metal toxicity studies?

For immunoprecipitation (IP) experiments investigating YIL014C-A's role in metal toxicity responses, consider these optimization strategies:

• Cell treatment: Expose yeast cells to various concentrations of metal ions (e.g., Zn²⁺, Al³⁺, As³⁺) based on established toxicity thresholds. For zinc studies, concentrations between 2-10 mM ZnSO₄ have been used in yeast models .

• Lysis buffer: Use a non-denaturing lysis buffer containing:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 1% NP-40 or Triton X-100

  • 5 mM EDTA

  • Protease inhibitor cocktail

  • Phosphatase inhibitors (if studying phosphorylation)

• Pre-clearing: Pre-clear lysates with protein A/G beads to reduce non-specific binding.

• Antibody coupling: Couple YIL014C-A antibodies to protein A/G beads (4 μg antibody per 50 μl bead slurry) for 1-2 hours at room temperature.

• Immunoprecipitation: Incubate pre-cleared lysates with antibody-coupled beads overnight at 4°C with gentle rotation.

• Washing: Perform stringent washes (at least 4-5) with lysis buffer containing reduced detergent.

• Elution: Elute bound proteins using either low pH buffer or by boiling in SDS sample buffer.

• Analysis: Analyze precipitated proteins by Western blotting or mass spectrometry to identify interaction partners that may change under metal stress conditions.

When studying metal ion effects, it's crucial to avoid metal chelators in buffers that might interfere with protein-metal interactions unless specifically testing such interactions .

How can YIL014C-A antibodies be used to investigate protein-protein interactions in metal stress response pathways?

YIL014C-A antibodies can be powerful tools for investigating protein-protein interactions in metal stress response pathways through several advanced approaches:

• Co-immunoprecipitation coupled with mass spectrometry:

  • Perform immunoprecipitation using YIL014C-A antibodies from cells exposed to different metal ions

  • Analyze co-precipitated proteins by mass spectrometry

  • Compare interaction profiles between control and metal-exposed conditions to identify stress-specific interaction partners

• Proximity-based labeling techniques:

  • Generate fusion proteins combining YIL014C-A with BioID or APEX2

  • Use YIL014C-A antibodies to confirm expression and localization

  • Identify proximal proteins that are biotinylated under different metal stress conditions

• Crosslinking immunoprecipitation (CLIP):

  • Apply UV crosslinking to capture transient interactions

  • Use YIL014C-A antibodies to isolate the protein and its interaction partners

  • This method is particularly useful for capturing dynamic interactions that occur during stress responses

Research has shown that protein kinase CK2 components interact differently under various metal stress conditions. For example, when investigating the role of CK2 in arsenic toxicity, researchers identified 29 deletion mutants with increased sensitivity and 11 with increased resistance to As³⁺ . Similar approaches could be applied to study YIL014C-A interactions, potentially revealing its role in metal detoxification pathways.

What is the role of YIL014C-A in cellular responses to zinc toxicity, and how can antibodies help elucidate this function?

Zinc toxicity research has revealed complex cellular responses in which YIL014C-A may play an important role. YIL014C-A antibodies can help elucidate these functions through several experimental approaches:

• Subcellular localization changes:

  • Use immunofluorescence with YIL014C-A antibodies to track protein localization before and after zinc exposure

  • Observe if the protein translocates to specific compartments under zinc stress

• Post-translational modifications:

  • Employ YIL014C-A antibodies in combination with modification-specific antibodies to detect changes in phosphorylation, ubiquitination, or other modifications

  • These modifications may regulate protein function during zinc stress

• Protein expression profiling:

  • Use Western blotting with YIL014C-A antibodies to quantify expression levels under varying zinc concentrations

  • Determine if expression is upregulated as part of stress response

Research has demonstrated that zinc homeostasis involves sophisticated mechanisms including the CKA1 subunit of protein kinase CK2, which plays a prominent role in zinc sequestration . Studies have shown that various CK2 deletion mutants have differential sensitivity to zinc, suggesting complex regulatory networks in which YIL014C-A may participate.

The table below summarizes experimental approaches for studying YIL014C-A's role in zinc toxicity responses:

How can researchers address cross-reactivity issues when using YIL014C-A antibodies in yeast studies?

Cross-reactivity can be a significant challenge when working with YIL014C-A antibodies, particularly in yeast studies. Here are methodological approaches to address this issue:

• Validation using knockout controls:

  • Always include yil014c-aΔ deletion mutant samples as negative controls

  • The absence of signal in knockout samples confirms antibody specificity

• Pre-absorption technique:

  • Incubate antibody with lysates from yil014c-aΔ strains before use

  • This pre-absorption removes antibodies that bind to non-specific epitopes

• Epitope competition assay:

  • Perform antibody incubation with and without purified YIL014C-A peptide

  • Specific signals should disappear when the antibody is blocked with the peptide

• Western blot optimization:

  • Increase stringency of washing steps (higher salt concentration, longer washes)

  • Test multiple antibody dilutions to find optimal signal-to-noise ratio

  • Use more stringent blocking conditions (5% BSA instead of milk for phospho-specific applications)

• Cross-species validation:

  • If available, test the antibody against homologous proteins from related yeast species

  • This helps establish evolutionary conservation of the epitope

When studying yeast genes and proteins, it's important to follow proper nomenclature conventions as noted in the provided documentation: genes are indicated by italicized capital letters (YIL014C-A), proteins by a capital first letter with a "p" suffix (Yil014c-ap), and deletion mutants by lowercase italics with delta (yil014c-aΔ) .

What are the key considerations when using YIL014C-A antibodies in experiments involving metal ion treatments?

When conducting experiments with YIL014C-A antibodies in the context of metal ion treatments, researchers should consider several critical factors:

• Metal ion interference with antibody binding:

  • High concentrations of metal ions (particularly Al³⁺, Zn²⁺, Cr⁶⁺, and As³⁺) may affect protein conformation or epitope accessibility

  • Include appropriate controls treated with metal ions but probed with well-characterized antibodies

• Buffer compatibility:

  • Avoid phosphate buffers when studying metal ions as they can precipitate with certain metals

  • Use HEPES or Tris buffers instead, adjusted to appropriate pH for the specific metal

• Chelator considerations:

  • Common additives like EDTA or EGTA will chelate metals and could disrupt physiologically relevant interactions

  • For metal-protein interaction studies, prepare separate buffers without chelators

• Sample preparation timing:

  • Process samples quickly after metal treatment to capture transient interactions

  • Consider using crosslinking agents to stabilize complexes before cell lysis

• Quantitative considerations:

  • Include dose-response experiments with various metal concentrations

  • In yeast studies, metal concentrations should be determined based on established toxicity thresholds (e.g., zinc sulfate at 2-10 mM, chromium trioxide at 0.1-1 mM, sodium arsenite at 0.2-0.4 mM)

• Control experiments:

  • Always include untreated controls for comparison

  • Consider using metal-specific fluorescent probes to confirm cellular uptake of metals

Research has shown that different CK2 subunits respond differently to metal treatments. For example, ICP-MS studies have been used to quantify chromium content in CK2 mutants compared to wildtype cells, revealing differential metal accumulation patterns . Similar approaches could be valuable when studying YIL014C-A.

How can YIL014C-A antibodies contribute to understanding metal ion dysregulation in neurodegenerative diseases?

While YIL014C-A is a yeast gene, studying its functions and interactions can provide valuable insights into conserved cellular mechanisms relevant to neurodegenerative diseases where metal ion dysregulation plays a critical role:

• Translational research approach:

  • Identify human homologs or functional analogs of YIL014C-A

  • Use YIL014C-A antibodies to confirm functional conservation in yeast models

  • Apply findings to mammalian neuronal cell models

• Metal homeostasis pathways:

  • Research has established connections between metal ion dysregulation and neurodegenerative diseases including Alzheimer's, Parkinson's, and ALS

  • Elevated zinc levels have been found in the substantia nigra of Parkinson's disease patients, suggesting zinc may be a risk factor

  • In Alzheimer's disease, zinc has been shown to precipitate Aβ peptides, leading to protease-resistant aggregates

• Cross-species experimental design:

  • Use YIL014C-A antibodies to study protein interactions in yeast under metal stress

  • Test if human neuronal proteins interact with similar partners under comparable conditions

  • Compare protein expression and localization patterns between yeast and neuronal models

• Protein kinase CK2 connection:

  • CK2 is highly conserved from yeast to humans

  • Studies in mammalian neuronal cells (SH-SY5Y and Neuro2a) have examined the effects of CK2 inhibition by TBB in the presence of metal ions

  • Understanding YIL014C-A's relationship with CK2 in yeast could inform similar studies in neuronal contexts

The table below summarizes relevant metals implicated in neurodegenerative diseases where YIL014C-A research might provide insights:

This research has significant implications, as understanding the molecular mechanisms of metal toxicity could lead to novel therapeutic approaches for these devastating conditions .

What experimental designs are recommended for comparative studies between yeast YIL014C-A and its mammalian homologs in neurodegenerative models?

When designing comparative studies between yeast YIL014C-A and potential mammalian homologs in neurodegenerative disease models, researchers should consider these methodological approaches:

• Homology identification and validation:

  • Use bioinformatics tools to identify potential mammalian homologs based on sequence, structure, or functional domains

  • Generate antibodies against both yeast YIL014C-A and identified mammalian proteins

  • Validate cross-reactivity and specificity in respective model systems

• Functional complementation assays:

  • Express mammalian homologs in yil014c-aΔ yeast strains

  • Use YIL014C-A antibodies to confirm absence of native protein

  • Test if mammalian proteins can rescue phenotypes associated with YIL014C-A deletion

  • Particularly focus on metal stress response phenotypes

• Parallel metal toxicity studies:

  • Expose both yeast and neuronal cells (e.g., SH-SY5Y, Neuro2a) to identical metal treatments

  • For neuronal cells, dose-response curves have been established for various metals:

    • Zinc sulfate: IC50 values range from 100-250 μM depending on cell line and exposure time

    • Chromium trioxide: IC50 values of approximately 20-30 μM

    • Sodium arsenite: IC50 values between 5-10 μM

    • Aluminum maltol: IC50 values of 250-500 μM

  • Compare localization and expression changes using respective antibodies

• Protein interaction network analysis:

  • Perform immunoprecipitation with YIL014C-A antibodies in yeast

  • Conduct parallel experiments with antibodies against mammalian homologs

  • Compare interaction partners under normal and metal stress conditions

  • Identify conserved interactions that might represent core metal response mechanisms

• Oxidative stress connections:

  • Research has shown that CK2 deletion mutants in yeast exhibit altered oxidation states after chromium exposure

  • Measure oxidative stress markers in both systems using appropriate indicators

  • Determine if YIL014C-A and mammalian homologs show similar relationships to redox homeostasis

• Gene expression modulation:

  • Use siRNA knockdown in neuronal cells to replicate deletion studies performed in yeast

  • Previous research has demonstrated that siRNA knockdown of CK2 subunits affects neuronal cell viability in the presence of metal ions

  • Compare phenotypes between systems to identify conserved pathways

These comparative approaches can help translate findings from the genetically tractable yeast system to more complex mammalian neuronal models, potentially identifying novel therapeutic targets for neurodegenerative diseases associated with metal dysregulation.